191 related articles for article (PubMed ID: 15371950)
81. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
[TBL] [Abstract][Full Text] [Related]
82. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
[TBL] [Abstract][Full Text] [Related]
83. Gonadoblastoma: Case report of two young patients with isochromosome 12p found in the dysgerminoma overgrowth component in one case.
Changchien YC; Haltrich I; Micsik T; Kiss E; Fónyad L; Papp G; Sápi Z
Pathol Res Pract; 2012 Oct; 208(10):628-32. PubMed ID: 22906432
[TBL] [Abstract][Full Text] [Related]
84. [An ovarian tumor with structural gonadoblastoma, dysgerminoma and choriocarcinoma].
Zuntová A; Motlík K; Horejsí J; Weinreb M
Cesk Patol; 1992 Aug; 28(3):175-81. PubMed ID: 1340402
[TBL] [Abstract][Full Text] [Related]
85. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors.
Ordi J; Romagosa C; Tavassoli FA; Nogales F; Palacin A; Condom E; Torné A; Cardesa A
Am J Surg Pathol; 2003 Feb; 27(2):178-86. PubMed ID: 12548163
[TBL] [Abstract][Full Text] [Related]
86. PRIMARY OVARIAN MALIGNANCY. REVIEW OF ONE HUNDRED CASES AT TWO HOSPITALS.
CARTER WF
Am J Obstet Gynecol; 1964 Dec; 90():651-6. PubMed ID: 14241504
[No Abstract] [Full Text] [Related]
87. Glypican-3 expression in clear cell adenocarcinoma of the ovary.
Maeda D; Ota S; Takazawa Y; Aburatani H; Nakagawa S; Yano T; Taketani Y; Kodama T; Fukayama M
Mod Pathol; 2009 Jun; 22(6):824-32. PubMed ID: 19329941
[TBL] [Abstract][Full Text] [Related]
88. [Gonadoblastoma with transformation to ovarian dysgerminoma. Apropos of 2 cases].
Rodríguez Fernández J; Navarro Pérez R; Rausell Segarra I; Carvajal Roca E; Ferrís i Tortajada J
An Esp Pediatr; 1999 Sep; 51(3):293-6. PubMed ID: 10575755
[No Abstract] [Full Text] [Related]
89. Expression of OCT4 and SALL4 in Diffuse Large B-cell Lymphoma: An Analysis of 145 Consecutive Cases and Testicular Lymphomas.
Williams AS; Shawwa A; Merrimen J; Dakin Haché K
Am J Surg Pathol; 2016 Jul; 40(7):950-7. PubMed ID: 27035612
[TBL] [Abstract][Full Text] [Related]
90. NUT protein immunoreactivity in ovarian germ cell tumours.
Iacobelli JF; Charles AK; Crook M; Stewart CJ
Pathology; 2015 Feb; 47(2):118-22. PubMed ID: 25551299
[TBL] [Abstract][Full Text] [Related]
91. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
92. Ovarian dysgerminomas in two mountain chicken frogs (Leptodactylus fallax).
Fitzgerald SD; Duncan AE; Tabaka C; Garner MM; Dieter A; Kiupel M
J Zoo Wildl Med; 2007 Mar; 38(1):150-3. PubMed ID: 17469294
[TBL] [Abstract][Full Text] [Related]
93. [Preserving ovarian function in the treatment of epithelial and special (other) malignant ovarian tumors].
Kolstad P
Geburtshilfe Frauenheilkd; 1987 Oct; 47(10):683-9. PubMed ID: 2824278
[TBL] [Abstract][Full Text] [Related]
94. The pathological assessment of ovarian neoplasms V: The germ cell tumours.
Russell P; Painter DM
Pathology; 1982 Jan; 14(1):47-72. PubMed ID: 7200599
[TBL] [Abstract][Full Text] [Related]
95. Seven tumor markers in benign and malignant germ cell tumors of the ovary.
Kawai M; Kano T; Kikkawa F; Morikawa Y; Oguchi H; Nakashima N; Ishizuka T; Kuzuya K; Ohta M; Arii Y
Gynecol Oncol; 1992 Jun; 45(3):248-53. PubMed ID: 1319383
[TBL] [Abstract][Full Text] [Related]
96. SEX CHROMATIN IN TUMORS OF THE OVARY.
TALVALKAR GV
Indian J Med Sci; 1963 Aug; 17():645-9. PubMed ID: 14060368
[No Abstract] [Full Text] [Related]
97. Dysgerminoma of the Ovary: An Analysis of 140 Cases Emphasizing Unusual Microscopic Findings and Resultant Diagnostic Problems.
Warnnissorn M; Watkins JC; Young RH
Am J Surg Pathol; 2021 Aug; 45(8):1009-1027. PubMed ID: 33577182
[TBL] [Abstract][Full Text] [Related]
98. Gonadoblastoma with coexistent features of mixed germ cell-sex cord stroma tumor: a case report.
Colafranceschi M; Massi D
Tumori; 1995; 81(3):215-8. PubMed ID: 7571033
[TBL] [Abstract][Full Text] [Related]
99. The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma.
Gimelli S; Beri S; Drabkin HA; Gambini C; Gregorio A; Fiorio P; Zuffardi O; Gemmill RM; Giorda R; Gimelli G
Mol Cancer; 2009 Jul; 8():52. PubMed ID: 19642973
[TBL] [Abstract][Full Text] [Related]
100. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
